- Advertisement -
- Advertisement -
- Advertisement -

Find a job

Subscribe for free

All things Pharma

COVID-19

Key covid-19 updates, government guidance and insight for pharma and health.

LATEST >

NICE guidance does not recommend AstraZeneca’s Evusheld

The National Institute for Health and Care Excellence (NICE) has issued draft guidance for public consultation which does not recommend Evusheld (tixagevimab-cilgavimab) for preventing...
- Advertisement -

Sanofi and GSK submit data for their COVID-19 vaccine

Sanofi and GlaxoSmithKline (GSK) have announced that they intend to submit data from both...

Success for world’s largest study into new antiviral treatments against COVID-19

Over ten thousand participants from across the UK have now taken part in the...

JCVI updates COVID-19 vaccination guidance for 5 to 11 year olds

The Joint Committee on Vaccination and Immunisation (JCVI) is now advising a non-urgent offer...
- Advertisement -
- Advertisement -

Pfizer and BioNTech initiate clinical study of Omicron vaccine

Pfizer and BioNTech have announced the initiation of a clinical study to evaluate the safety,...

MHRA approves Pfizer’s COVID-19 antiviral treatment Paxlovid

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved COVID-19 antiviral treatment, Paxlovid...

UK marks 132 million COVID-19 vaccinations in 2021

Around 132 million COVID-19 vaccinations were administered across all four nations of the UK in 2021, as part of the largest vaccination programme in...

COVID: A new wave of interest in pharma, what learnings can we take into the future?

"We have a responsibility to build on this extraordinary period of self-education and find ways of talking about what we do – beyond vaccines"

Subscribe

Sign up to receive our digital newsletter, for all the essential headlines, Jobs of the Week and thought-provoking features.

Claim my free subscription